Mohammed Suleiman

Dr. Mohammed Suleiman

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2021 in Microbiology Spectrum
Verified
Journal Article
Open access
AKAhmed S. Keshta
Ahmed S. Keshta
NENazik Elamin
Nazik Elamin
MHMohammad Rubayet Hasan
Mohammad Rubayet Hasan
APAndrés Pérez-López
Andrés Pérez-López
DRDiane Roscoe
Diane Roscoe
MSMohammed Suleiman
Mohammed Suleiman
The incidence of bloodstream infections (BSI) with extended spectrum beta-lactamase (ESBL) producing and carbapenemase producing Enterobacterales (CPE) is increasing at an alarming rate, for which only limited therapeutic options remain available. Rapid identification of these bacteria along with their antibiotic resistance mechanisms in positive blood cultures with Gram-negative bacteria will allow for early initiation of effective therapy and limit the overuse of broad-spectrum antibiotics in BSI (1).

22 December 2021 in Microbiology Spectrum
Verified
Journal Article
Open access
APAndrés Pérez-López
Andrés Pérez-López
SSSathyavathi Sundararaju
Sathyavathi Sundararaju
KTKin Ming Tsui
Kin Ming Tsui
HMHassan Al Mana
Hassan Al Mana
MHMohammad Rubayet Hasan
Mohammad Rubayet Hasan
PTPatrick Tang
Patrick Tang
To the best of our knowledge, this is the first study addressing the molecular characteristics of CPE in a pediatric population in Qatar using whole-genome sequencing. Since several countries in the Arabian Peninsula share relatively similar demographic patterns and international links, it is plausible that the molecular characteristics of CPE in children, at least in the middle and eastern parts of the region, are similar to those observed in our study.

23 September 2022 in Journal of Travel Medicine
Verified
Journal Article
Open access
PDF file
APAndrés Pérez-López
Andrés Pérez-López
HMHassan Al Mana
Hassan Al Mana
MIMuhammad Iqbal
Muhammad Iqbal
MSMohammed Suleiman
Mohammed Suleiman
MHMohammad Rubayet Hasan
Mohammad Rubayet Hasan
PTPatrick Tang
Patrick Tang
The implementation of non-pharmaceutical measures and restrictions on international travel to mitigate the spread of coronavirus disease 2019 (COVID-19) have impacted the spread and seasonality of several respiratory viruses worldwide, including influenza A virus. 1–3 Qatar is small country in the Northeast coast of the Arabian Peninsula with a subtropical desert climate. Before the introduction of COVID-19 restrictions, influenza A circulated in Qatar throughout the year with a largest peak of infection between November and December, and a secondary peak of variable amplitude between March and April. 4 Here, we assessed trends in influenza A infection rates in children during the COVID-19 pandemic in Qatar.

18 August 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
PMPrincess Elizabeth Morales
Princess Elizabeth Morales
PTPatrick Tang
Patrick Tang
EMElaine Mariano
Elaine Mariano
AGArun Gopalan
Arun Gopalan
NANisha Aji
Nisha Aji
MSMohammed Suleiman
Mohammed Suleiman
Bloodstream infections (BSIs) are life-threatening infections for which a timely initiation of appropriate antimicrobial therapy is critical. Antibiotic susceptibility testing (AST) directly performed on positive blood culture broths can help initiate targeted antibiotic therapy sooner than the standard AST performed on colonies isolated on solid media after overnight incubation. Faster antimicrobial susceptibility testing (AST) results can improve clinical outcomes, and reduce broad-spectrum antimicrobial consumption and healthcare-associated costs in sepsis. In this study, we evaluated the accuracy of a direct AST inoculation method on the BD Phoenix M50 system using serum separator tubes to harvest bacteria from positive pediatric blood culture bottles. Direct AST was performed on 132 monomicrobial pediatric blood culture bottles that were positive for Enterobacterales (65; 49.2%), Staphylococcus aureus (46; 34.8%), and non-fermenting Gram-negative bacilli (21; 16%). Overall, the categorical and essential agreements between the direct method and standard method were 99.6% and 99.8%, respectively. Very major, major, and minor error rates were 0.1%, 0.09%, and 0.20% respectively. Direct AST performed on pediatric blood culture bottles using BD Phoenix M50 can quickly provide accurate susceptibility information to guide antimicrobial therapy in patients with BSI.

10 November 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
MSMohammed Suleiman
Mohammed Suleiman
MIMuhammad Iqbal
Muhammad Iqbal
PTPatrick Tang
Patrick Tang
APAndrés Pérez-López
Andrés Pérez-López
Accurate laboratory diagnosis of gastroenteritis is important to ensure that patients receive appropriate treatment and proper isolation precautions. This study evaluated the performance of the QIAGEN QIAstat-Dx gastrointestinal panel (QGP) in comparison to the bioMerieux BioFire FilmArray gastrointestinal panel (BGP) for the detection of gastrointestinal pathogens in 110 pediatric patients being evaluated for gastroenteritis at our hospital. We compared 23 different bacterial, viral, and parasite enteropathogens detected by the QGP against the BGP. The overall positive percent agreement (PPA) for all compared targets was 96.2% and the overall negative percent agreement (NPA) for all compared targets was 99.7%. Our study shows that QIAstat-Dx QGP provides comparable results to the BioFire BGP in our pediatric population. Additionally, the PCR cycle threshold (Ct) value reported by the QGP is potentially a helpful tool in estimating the load of the detected pathogen in stool samples.

23 May 2022 in Journal of Travel Medicine
Verified
Journal Article
Open access
PDF file
APAndrés Pérez-López
Andrés Pérez-López
HMHassan Al Mana
Hassan Al Mana
MIMuhammad Iqbal
Muhammad Iqbal
MSMohammed Suleiman
Mohammed Suleiman
MHMohammad Rubayet Hasan
Mohammad Rubayet Hasan
PTPatrick Tang
Patrick Tang
The introduction of non-pharmaceutical measures to mitigate the spread of coronavirus disease 2019 (COVID-19) has disrupted the seasonality of respiratory syncytial virus (RSV) worldwide. There was a near absence of RSV during the fall and winter of 2020–2021 with the implementation of restrictions, followed by an unusual re-emergence in the summer months coinciding with their relaxation. 1–6